Integration of the B-Cell Receptor Antigen Neurabin-I/SAMD14 Into an Antibody Format as New Therapeutic Approach for the Treatment of Primary CNS Lymphoma-Reference-Cited by-同舟云学术

Integration of the B-Cell Receptor Antigen Neurabin-I/SAMD14 Into an Antibody Format as New Therapeutic Approach for the Treatment of Primary CNS Lymphoma

Published:2020-11-12 Issue: Volume:10 Page:
ISSN:2234-943X
Container-title:Frontiers in Oncology
language:
Short-container-title:Front. Oncol.

Author:

Bewarder Moritz,Kiefer Maximilian,Moelle Clara,Goerens Lisa,Stilgenbauer Stephan,Christofyllakis Konstantinos,Kaddu-Mulindwa Dominic,Fadle Natalie,Regitz Evi,Neumann Frank,Hoth Markus,Preuss Klaus-Dieter,Pfreundschuh Michael,Thurner Lorenz

Publisher

Frontiers Media SA

Subject

Cancer Research,Oncology

Reference45 articles.

1. The 2016 revision of the World Health Organization classification of lymphoid neoplasms;Swerdlow;Blood,2016

2. Age, gender, and racial differences in incidence and survival in primary CNS lymphoma;Villano;Br J Cancer,2011

3. Primary CNS lymphoma;Schlegel;Ther Adv Neurol Disord,2009

4. Gene expression profiling suggests primary central nervous system lymphomas to be derived from a late germinal center B cell;Montesinos-Rongen;Leukemia,2008

5. Primary central nervous system lymphomas are derived from germinal-center B cells and show a preferential usage of the V4-34 gene segment;Montesinos-Rongen;Am J Pathol,1999

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hyper-N-glycosylated SEL1L3 as auto-antigenic B-cell receptor target of primary vitreoretinal lymphomas;Scientific Reports;2024-04-26

2. Ars2‐containing bispecific, Fab‐ and IgG1‐format BAR‐bodies to target DLBCL cells;eJHaem;2022-12-27

3. Autoantibodies against SUMO1-DHX35 in long-COVID;Journal of Translational Autoimmunity;2022

4. The B-cell Receptor Autoantigen LRPAP1 Can Replace Variable Antibody Regions to Target Mantle Cell Lymphoma Cells;HemaSphere;2021-07-13